US WorldMeds

US WorldMeds is a drug discovery company in Louisville, United States, founded in 2001. It has raised $30.0M across 1 round, most recently a $30.0M Venture Round in April 2018.

Making a Difference, Patient by Patient

Headquarters
Louisville
Employees
51–200
Founded
2001
Total Funding
$30.0M
Last Round
$30.0M Venture RoundApr 2018
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

US WorldMeds is a privately held specialty pharmaceutical company that licenses, develops, and delivers medicines for patients with rare and challenging conditions, including high-risk neuroblastoma, malignant hyperthermia, and synovial sarcoma. The company's mission is to develop, license, and market meaningful and accessible healthcare products that improve lives and result in a thriving community of patients, employees, and shareholders. US WorldMeds is headquartered in Louisville, Kentucky, and has announced FDA approvals including TECELRA (afamitresgene autoleucel) and IWILFIN (eflornithine) for pediatric cancer treatment.

Summary

It lists 51–200 employees. It has raised $30.0M in total across 1 round, most recently a $30.0M Venture Round in Apr 2018.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundApr 2018
$30.0M

Similar Companies

Shields Health Solutions

The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...

United StatesHealthcare, Drug Discovery
Corporate RoundTotal funding$3.5BSep 2025
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

US WorldMeds on Indexed.vc
<a href="https://indexed.vc/companies/us-worldmeds"><img src="https://indexed.vc/api/badge/company/us-worldmeds" alt="US WorldMeds on Indexed.vc" width="260" height="76" /></a>